Search

everythinglearnresearchcommunity

for

Search:↓

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Hair dyes and perms can damage hair and scalp, but using interventions can reduce harm.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.